Suhaib M Muflih

Suhaib M Muflih

Tanzania

Publications
  • Research Article
    Pharmacogenetic Testing for Methotrexate Treatment in Leukemia Patients
    Author(s): Muhammad Tahir M Bhinder, Amin Saleh Halum, Suhaib M Muflih and Mohammad Shawaqfeh Muhammad Tahir M Bhinder, Amin Saleh Halum, Suhaib M Muflih and Mohammad Shawaqfeh

    Background: Pharmacogenetic testing can be used as a means to individualize a patient’s medical regimen in order to prevent future adverse drug events. Pharmacogenomics looks at individual genes and can predetermine a patient’s susceptibility to certain side effects of medications, as well as how efficacious a medication will be for that patient. Methotrexate has been shown to exhibit different responses based on the genetic expressions and variations of the genes SLC19A, SHMT, ABCB1, ATIC and MTHFR. Objective: To determine the clinical relevance of pharamcogenetic testing for leukaemia patients treated with Methotrexate. Method: A systematic review was conducted from September 2013-August 2015, primarily using the EMBASE and PubMed databases, identifying Cochrane reviews, controlled clinical trials, ra.. View More»
    DOI: 10.4172/2167-7956.1000134

    Abstract PDF